HistoSonics Does First Treatment Using Ultrasound Therapy
ANN ARBOR - HistoSonics announced Tuesday the first treatment of a patient with BPH using its Vortx RX device at the University of Michigan Department of Urology. The Vortx RX is based on histotripsy technology, a non-thermal focused ultrasound therapy that mechanically liquefies targeted tissues. The Vortx RX is an investigational device and is limited